Alternative Data for ESSA Pharma
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Sentiment | 100 | Sign up | Sign up | Sign up |
| Webpage traffic | N/A | Sign up | Sign up | Sign up |
| Google Trends | N/A | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 3,092 | Sign up | Sign up | Sign up |
| X Mentions | 1 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
About ESSA Pharma
ESSA Pharma Inc., a clinical-stage pharmaceutical company, is focused on developing novel and proprietary therapies for the treatment of prostate cancer. The company is headquartered in Vancouver, Canada.
| Price | $0.20 |
| Target Price | Sign up |
| Volume | 5,950,000 |
| Market Cap | $9.5M |
| Year Range | $0.19 - $0.78 |
| Dividend Yield | 87.6% |
| Analyst Rating | 0% buy |
| Industry | Biotechnology |
In the news
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q2 '25 | 0 | 16,000 | -16,000 | -4M | -5M | -0.090 |
| Q1 '25 | 0 | 24,000 | -24,000 | -6.4M | -6.4M | -0.140 |
| Q4 '24 | 0 | 23,000 | -23,000 | -8.5M | -8.5M | -0.272 |
| Q3 '24 | 140,000 | 68,000 | 68,000 | -6.4M | -6.3M | -0.199 |
| Q2 '24 | 0 | 23,000 | -23,000 | -7.2M | -7.2M | -0.160 |
Insider Transactions View All
| BIOTECHNOLOGY VALUE FUND L P filed to sell 560,797 shares at $1.9. August 7 '25 |
| BIOTECHNOLOGY VALUE FUND L P filed to sell 4,726,743 shares at $1.9. August 7 '25 |
| BIOTECHNOLOGY VALUE FUND L P filed to sell 6,194,145 shares at $1.9. August 7 '25 |
| BB BIOTECH AG filed to sell 1,879,583 shares at $1.5. November 5 '24 |
Similar companies
Read more about ESSA Pharma (EPIX) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, sentiment, webpage traffic, google trends, 4chan mentions, reddit mentions, stocktwits mentions, stocktwits subscribers, x mentions, news mentions & customer reviews.
FAQ - ESSA Pharma
The Market Cap of ESSA Pharma is $9.5M.
Currently, the price of one share of ESSA Pharma stock is $0.20.
The EPIX stock price chart above provides a comprehensive visual representation of ESSA Pharma's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling ESSA Pharma shares. Our platform offers an up-to-date EPIX stock price chart, along with technical data analysis and alternative data insights.
Yes, ESSA Pharma (EPIX) offers dividends to its shareholders, with a dividend yield of 87.6%. This dividend yield represents ESSA Pharma's commitment to providing value to its shareholders through both potential capital appreciation and steady income. Investors considering ESSA Pharma in their portfolio should factor in this dividend policy alongside the company's growth prospects and market position.
Some of the similar stocks of ESSA Pharma are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
